CAFs can misdirect CTLs into the stromal area outside the tumor through the CXCL12–CXCR4 axis, thereby directing T cells to the mesenchymal region and preventing them from recognizing and eliminating cancer cells. The gene discussed is CXCL12; the disease is neoplasm.